BioWorld

Jan. 8, 2007

Most Signals Suggest A Positive 2007 For Biotech

A number of signs point to some promising new and continuing trends for the biotech industry in the year ahead, observers are saying, with myriad financial opportunities available to companies and investors alike. (BioWorld Today) Read More

Despite Decades Of Change, Industry Tradition Carries On

Sequoia's $35M Series C To Support Two Clinical Trials

OSI, Lilly Sign Potential $385M Deal For GKA Drugs In Diabetes

Clinic Roundup

Other News To Note

U.S. Patent Disclosures

Today's news in brief

BioWorld

BioWorld briefs for July 21, 2026.

ALN-5288 lowers tau levels in preclinical models

BioWorld Science

Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....

LIT-002 is strong candidate for autism and neuropathic pain

BioWorld Science

Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

New biomarker may improve RSV drug screening

BioWorld

Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...